Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder — Stella

Home/Alcohol Use Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Alcohol Use Disorder trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Yale University, New Haven, Connecticut

Key details

Phase

Very early testing

Sponsor

Yale University

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Enrollment target

~100 participants

Started

November 2023

Primary completion

August 2028

Age range

21 Years – 70 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.